Newsfile Corp
03 Dec 2025, 00:04 UTC · 42w ago
Verdict
Headline takes no side. We score BAX −1.00 across three claims — strongly bearish.
−1.00strongly bearish
More negative than 95% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish
Baxter International has voluntarily and temporarily paused shipments and planned installations of the Novum LVP.
More negative than 99% of claims this week
The Novum LVP is alleged to have systemic defects causing underinfusion, overinfusion, and non-delivery of fluids, resulting in patient injuries and deaths.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
More negative than 98% of claims this week
A federal securities class action lawsuit has been filed alleging that Baxter executives made false or misleading statements regarding the safety and efficacy of the Novum LVP.
More negative than 86% of claims this week
Which stocks this story touches
More negative than 95% of ticker scores this week
The company is facing a federal securities class action lawsuit following allegations of systemic defects in its Novum LVP pumps and a subsequent 22.4% stock drop.
More negative than 76% of ticker scores this week
The company is mentioned in the context of a securities class action lawsuit deadline.
More negative than 76% of ticker scores this week
The company is mentioned in the context of a securities class action lawsuit deadline.
More negative than 76% of ticker scores this week
The company is mentioned in the context of a securities class action lawsuit deadline.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
PRNewsWire
15h ago
+24.7%
Price is moving against the score
$23.48 vs $18.84 close before publication (Dec 2) · not market-adjusted
BAX chart →
